drugset / Trial / NCT02194400
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A one month multi-dose study will evaluate the safety and tolerability of 3 intravenous infusions of RSLV-132 in subjects with inactive to mild SLE.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RSLV-132 | Protein / enzyme biologic | 0.3 mg/kg | Intravenous |
| Subject | RSLV-132 | Protein / enzyme biologic | 10 mg/kg | Intravenous |